The importance to update the guidelines for the use of genetic testing in noncancer patients in Brazil

• Autor(a) principal: Lajus,Tirzah Braz Petta
• Data de Publicação: 2015
• Tipo de documento: Relatório
• Idioma: eng
• Título da fonte: Revista de Saúde Pública
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102015000100603
• topic: Supplemental Health; Health Maintenance Organizations; Private Health Care Coverage; Genetic Testing; Genetic Predisposition to Disease; Neoplasms, diagnosis

The Brazilian National Regulatory Agency for Private Health Insurance and Plans has recently published a technical note defining the criteria for the coverage of genetic testing to diagnose hereditary cancer. In this study we show the case of a patient with a breast lesion and an extensive history of cancer referred to a private service of genetic counseling. The patient met both criteria for hereditary breast and colorectal cancer syndrome screening. Her private insurance denied coverage for genetic testing because she lacks current or previous cancer diagnosis. After she appealed by lawsuit, the court was favorable and the test was performed using next-generation sequencing. A deletion of MLH1 exon 8 was found. We highlight the importance to offer genetic testing using multigene analysis for noncancer patients.